John Gill, Director at Altimmune, Inc. (ALT), bought 25,000 shares at $4.10 ($103K) on 2025-12-23, disclosed to the SEC on 2025-12-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.10 | 12,500 | $51K | 50.0% |
| 2 | $4.10 | 12,500 | $51K | 50.0% |
| Total | $4.10 avg | 25,000 | $103K | 100% |
| Filing → |
| ALT | SELL | 2020-12-02 | $100K | — | Filing → |
| ALT | BUY | 2017-06-06 | $4K | — | Filing → |